BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Diagnosis
14 results:

  • 1. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
    Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
    J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The critical role of phlebolymphedema in cellulitis associated with lymphedema: Its incidence and economic impact in a large real-world population.
    Tedesco A; O'Donnell T; Weycker D; Salehi P
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101704. PubMed ID: 37977518
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
    Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutational signatures for breast cancer diagnosis using artificial intelligence.
    Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
    J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Au-TiO
    Chaudhary VS; Kumar D; Kumar S
    IEEE Trans Nanobioscience; 2023 Jul; 22(3):562-569. PubMed ID: 36327178
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
    Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
    Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proteogenomic and metabolomic characterization of human glioblastoma.
    Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L;
    Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women].
    Shen SJ; Xu YL; Zhou YD; Ren GS; Jiang J; Jiang HC; Zhang J; Li B; Jin F; Li YP; Xie FM; Shi Y; Wang ZD; Sun M; Yuan SH; Yu JJ; Chen Y; Sun Q
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):109-115. PubMed ID: 33378802
    [No Abstract]    [Full Text] [Related]  

  • 9. Can Radiologic Tumor Size Following Neoadjuvant Therapy Reliably Guide Tissue Resection in breast Conserving Surgery in Patients with Invasive breast cancer?
    Walcott-Sapp S; Srour MK; Lee M; Luu M; Amersi F; Giuliano A; Chung A
    Am Surg; 2020 Oct; 86(10):1248-1253. PubMed ID: 33284669
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA breast cancer.
    Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
    Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Improving Patient Care by Incorporation of Multidisciplinary breast Radiology-Pathology Correlation Conference.
    Prakash S; Venkataraman S; Slanetz PJ; Dialani V; Fein-Zachary V; Littlehale N; Mehta TS
    Can Assoc Radiol J; 2016 May; 67(2):122-9. PubMed ID: 26632099
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
    Weigel MT; Ghazoui Z; Dunbier A; Pancholi S; Dowsett M; Martin LA
    Breast Cancer Res; 2012 May; 14(3):R78. PubMed ID: 22608253
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
    Tischkowitz M; Brunet JS; Bégin LR; Huntsman DG; Cheang MC; Akslen LA; Nielsen TO; Foulkes WD
    BMC Cancer; 2007 Jul; 7():134. PubMed ID: 17650314
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.